From insufficiency to anticipation, an introduction to 'Lichaamskaart'

In this paper we take up the point of symbolic-imaginary anticipation and we combine it with the mirror stage, worked out by Jacques Lacan in numerous publications. We place the mirror stage within its complex temporal framework and explain how the three topological categories (RSI) follow from this most intimate of subjective experiences in the double mirror set up. All kinds of psychopathological mechanisms are traceable to this period in subjective development. Until recently it was impossible to find direct traces of this defining and unchanging moment. Since the beginning of 1990 a new method of therapy was devised in Duffel, named ‘lichaamskaart’, or body map. We point out the likeness and differences between the double mirror stage and the construction of the lichaamskaart. In conclusion we illustrate the relationship between anticipatory systems and the therapeutic process involved in lichaamskaart

De milieuaspecten van het Zeekanaal: kwaliteit en sanering van de waterbodem

The Seacanal to Ghent. the water as well as the sediments, are heavily polluted due to the input of contamination coming from upstream and from wastewater of the industries along its banks. The application of Dutch and Flemish classification criteria defines the sediment as highly polluted. which removal and disposal requires special care. This article starts with considerations about the quantitative aspects of the sediments. Next, the quality is assessed. which is not at all easy regarding the continuous variation of the input and the output. Nevertheless a double approach is described: a pre and a post dredging approach. Starting from general ideas about remedial action for sediments, a script for the remediation of the Seacanal is proposed. The article ends with a brief description of the pratical consequences of the proposed script

The EU Legislation on GMOs - An Overview

Genetic modification, also known as "genetic engineering¿ or ¿recombinant-DNA technology¿ was first applied in the 1970¿s. As an application of modern biotechnology, this technique allows selected individual genes to be transferred from one organism into another, also between non-related species. It is therefore one of the methods to introduce novel traits or characteristics into micro-organisms, plants and animals. The products obtained from this technology are commonly called "Genetically Modified Organisms (GMOs). Genetically modified organisms (GMOs) are officially defined in the EU legislation as "organisms in which the genetic material (DNA) has been altered in a way that does not occur naturally by mating or natural recombination". The most common types of GMOs that have been developed and commercialised so far are genetically modified crop plant species, such as genetically modified maize, soybean, oilseed rape and cotton varieties. Such varieties have, in the main, been genetically modified to provide resistance to certain insect pests and/or tolerance to herbicides. The application of this technology is strictly regulated and the European Union has established an extensive legal framework on GMOs since the early 1990s. This specific legislation has two main objectives: - To protect health and the environment : a genetically modified organism (GMO) or a food product derived from a GMO can only be put on the market in the EU after it has been authorised on the basis of a detailed EU procedure based on a scientific assessment of the risks to health and the environment. - To ensure the free movement of safe and healthy genetically modified products in the European Union: once authorised on the basis of the strict EU GMO authorisation procedure, genetically modified products can be placed on the whole EU market. The entire corpus of European GMO legislation has been amended between 2000 and 2003, leading to the creation of a whole updated EU legal framework on GMOs as of 2003.JRC.DG.I.4-Molecular biology and genomic

Study of the Completion of Follow-up After Helicobacter Pylori Eradication Therapy

Background: Because no therapeutic regimens have an eradication rate of 100%, post-treatment evaluation is necessary to ensure that adequate eradication therapy for Helicobacter pylori has been provided. The fact that not all patients are evaluated after eradication therapy is a serious concern for both the medical care system and medical economy.Method: We performed a retrospective study of 411 patients who received first-line H. pylori eradication therapy at Fuyoukai Murakami Hospital from October 1, 2014 to March 31, 2016. We calculated the rate of post-treatment follow-up at 1 year after completing the eradication therapy. In addition, we excluded 76 patients who definitely received post-treatment evaluation because of follow-up appointments with gastroenterologists (n = 29) or return visits to other physicians (n = 47) and included 335 patients in the final study population. We used logistic regression models for identifying the relevant factors contributing to the completion of post-eradication follow-up.Results: The rate of completion of post-eradication follow-up was 78.8% (324/411). Multivariate analysis revealed that the adjusted odds ratios for age (≥ 48 years), gender (female) and preventive measures for gastric cancer (esophagogastroduodenoscopy after radiographic screening for gastric cancer and a desire to be examined for H. pylori infection) were 1.85 [95% confidence interval (CI): 1.11–3.09; p < 0.05], 1.89 [95% CI: 1.07–3.34; p < 0.05] and 4.01 [95% CI: 1.61–10.0; p < 0.01], respectively.Conclusion: Age ≥ 48 years, female gender and preventive measures for gastric cancer were independently related to a higher rate of completion of post-eradication follow-up

Fuzzy-logic based procedures for GMO Analysis

A monitoring system for GMOs (Genetically Modified Organisms) and GMO-derived products in the food and feed chains has been established in the European Union (EU) - . In previous letters to your journal - , challenges were highlighted to implement EU regulations for labeling of products containing GMOs. Test methods for monitoring GMOs are based mainly on the Polymerase Chain Reaction (PCR).JRC.I.3-Molecular Biology and Genomic

Technical Guidance Document from the European Union Reference Laboratory for Genetically Modified Food and Feed on the Implementation of Commission Regulation (EU) No 619/2011

The recently adopted Commission Regulation (EU) No 619/2011 lays down the methods for sampling and analysis for the official control of food as regards to presence of genetically modified material for which an authorisation procedure is pending or the authorisation of which is has expired (the so-called LLP, Low Level presence Regulation). The requirements of this Regulation are technically demanding because they set a non-compliance limit of 0.1% GMO (mass fraction). The European Union Reference Laboratory for Genetically Modified Food and Feed (EU-RL GMFF) plays a crucial role in the implementation of this regulation because only methods validated by the EU-RL that show a RSDr value of maximum 25% at the level of 0.1% related to mass fraction of GM material can be used on falling under that regulation. The aim of this document is to explain how this Regulation will affect the process of validation and how laboratories need to operate under that Regulation.JRC.I.3-Molecular Biology and Genomic